China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2015 Financial Results
HONG KONG, Nov. 18, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2015 onTuesday, November 25, 2014, after market close in the US. The Company will host a c...
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014
HONG KONG, Sept. 26, 2014 /PRNewswire/ --China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2014...
China Cord Blood Corporation to Incentivize Management Team with Share Awards
HONG KONG, Sept. 5, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company's Compensation Co...
China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results
HONG KONG, Aug. 29, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial...
China Cord Blood Corporation Receives Notice of Transaction Regarding its 7% Senior Convertible Note Due 2017 Held by Golden Meditech
HONG KONG, Aug. 25, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed ...
China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results
HONG KONG, Aug. 21, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first quarter of fiscal year 2015 onThursday, August 28, 2014, after market close in the US. The Company will host a conference call at ...
China Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 31, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with...
China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy
HONG KONG, July 23, 2014 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, andCordlife Group Limited ("Cordli...
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2014
HONG KONG, June 19, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial r...
China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2014 Financial Results
HONG KONG, June 11, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the fourth quarter and full fiscal year ended March 31, 2014 on Wednesday, June 18, 2014, after the market closes in the U.S. The Company will ho...
China Cord Blood Corporation Announces Resignation of Director
HONG KONG, Sept. 30, 2013 /PRNewswire/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC"or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that Mr. Jeremy Yee has resigned as an...
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2014
1Q14 Added 15,260 New Subscribers 1Q14 Revenue Up 11.6% YOY to RMB128.7 Million 1Q14 Operating Income Up 3.3% YOY to RMB45.9 Million Conference Call to be Held August 27, 2013 at 8:00 a.m. ET HONG KONG, Aug. 26, 2013 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Com...
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
4Q13 Added 16,059 New Subscribers 4Q13 Revenue Up 33.3% YOY to RMB133.0 Million 4Q13 Operating Income Up 45.6% to RMB50.7 Million Conference Call to be Held June 19, 2013 at 8:00 a.m. ET HONG KONG, June 18, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("C...
China Cord Blood Corporation Received AABB Accreditation
HONG KONG, April 2, 2013 /PRNewswire/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the cord blood bank operated by its Beijing subsidiary has been granted the AABB Accreditation, as a certificati...
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
3Q13 New Subscribers Up 65.0% YOY to 21,218 3Q13 Revenue Up 57.5% YOY to RMB149.3 Million 3Q13 Operating Income Up 112.9% YOY to RMB67.1 Million Conference Call to be Held February 27, 2013 at 8:00 a.m. ET HONG KONG, Feb. 27, 2013 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (...
China Cord Blood Corporation Announces Participation in the 31st Annual J.P. Morgan Healthcare Conference
HONG KONG, Dec. 27, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company will participate in the 31st Annual J.P. Morgan Healthcare Conference to be held January 7...
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operating Income Up 24.7% to RMB47.0 Million Conference Call to be Held November 20, 2012 at 8:00 a.m. ET HONG KONG, Nov. 20, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC...
China Cord Blood Corporation Continues Share Repurchase Program
HONG KONG, Oct. 22, 2012 /PRNewswire/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that the Company repurchased an aggregate of 6,041,980 ordinary shares for a total consideration of approximately $16...
China Cord Blood Corporation Announces Completion of $50 Million Convertible Note Financing with Golden Meditech
HONG KONG, Oct. 3, 2012 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, announced that it has successfully completed the previously announced $50 million convertible note financing with Golden Meditech Hol...
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013
1Q13 New Subscribers Up 28.3% to 16,460 1Q13 Revenue Up 31.9% YOY to RMB115.3 Million 1Q13 Operating Income Up 44.4% to RMB44.4 Million Conference Call to be Held August 23, 2012 at 8:00 a.m. ET HONG KONG, Aug. 23, 2012 /PRNewswire-Asia/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" ...
